Global Menstrual Cramps Treatment Market: Key Developments
On December 28, 2020, Myovant Sciences Ltd, a subsidiary of Sumitovant Biopharma Ltd, a biopharmaceutical company, and Pfizer. Inc., a U.S.-based multinational pharmaceutical and biotechnology corporation, collaborated for development and commercialization of Relugolix for treatment of heavy menstrual bleeding associated with uterine fibroids and endometriosis.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients